Market Research Reports

Prostate Cancer Minimally Invasive Surgery Market in North America and Europe (2011 - 2016)

83pages
Published Date: 2011-11-09
 

Description


The prostate cancer market is set to grow in the coming future, owing to the fact that it is the second most leading cause of cancer among men after lung cancer. In 2010, more than 1.9 million people have been diagnosed with prostate cancer across the world. African Americans and Whites are most affected with this disease. Old age, heredity, lifestyle aspects such as smoking and diet rich in red meat are the major factors increasing the risk of getting prostate cancer.

Surgical robots are the most critical innovation in the past decade. It has revolutionized the prostate cancer minimally invasive surgery market. Though the cost of a surgical robot is close to USD 1.5 million, its adoption is getting popular. Better control during surgery, dexterity, lesser risk of side effects such as impotency, shorter hospital stay, lesser pain, quicker recovery are some of the major factors fuelling the growth of robots assisted surgery.

This study will help
  • To analyze, estimate and forecast the minimally invasive surgical devices market for treating prostate cancer
  • To identify the drivers, restraints and opportunities for the prostate cancer minimally invasive market
  • To identify the trends, burning issues, and growth prospects for the prostate cancer minimally invasive market
  • To identify the major market players and determine their respective market share, core competencies
  • To profile the key market players and analyze their market strategies and recent developments 
Scope

The scope of the study is defined as below:

  • Type of minimally invasive prostate cancer surgery- Laparoscopic, Brachytherapy, Cryosurgery, Robot Assisted and others
  • Types of surgical devices- Endosurgical Equipment, Monitoring & Visualizing Devices, Lasers and more
  • Stages of disease progression- Stage A, Stage B, Stage C and Stage D
  • Geographies covered- North America and Europe

Methodology

  • Intensive secondary research will be conducted to study the background of the prostate cancer surgery market. It will help in understanding the dynamics of available surgical options and ongoing developments
  • Market will be segmented as per the surgery type, products and disease progression. Drivers, restraints and opportunities with respect to the various segments will be studied to analyze the market trend
  • Key players will be identified and market strategies, product lines, market penetration and other factors will be analyzed to estimate their respective market share
  • Primary interviews with key industry participants like Oncologists, Directors, CEOs and Managers from major industry players will be conducted to get the key market information and triangulate the analysis
  • Market will be forecasted considering the ongoing developments and trends. Strategic recommendations will be provided based on the overall analysis

Stakeholders

  • Surgical device manufacturers
  • Surgical device distributers
  • Key opinion leaders (KOLs)/ decision makers at various healthcare provider facilities
  • Out-patient surgery clinics
  • Business research and management consulting organizations

Table of Contents


Table of Content

CHAPTER 1 - SUMMARY - Prostate Cancer Market And Minimally Invasive Surgery Market 
1.1 MARKKET SCENARIO
1.2 KEY TRENDS &  INNOVATIONS
1.3 KEY PLAYERS

CHAPTER 2 - INTRODUCTION
2.1 RESEARCH OBJECTIVES
2.2 SCOPE OF THE REPORT
2.3 MARKETS COVERED
2.4 METHODOLOGY
     2.4.1 PRIMARY SURVEY
     2.4.2 SECONDARY RESEARCH
     2.4.3 MARKET SIZING
2.5 FORECAST ASSUMPTIONS

CHAPTER 3 - MARKET OVERVIEW
3.1 INTRODUCTION
3.2 PROSTATE CANCER: INTRODUCTION
3.3 EPIDEMIOLOGY
3.4 SYMPTOMS
3.5 RISK FACTORS
     3.5.1 AGE
     3.5.2 ETHNICITY
     3.5.3 FAMILY HISTORY/GENETICS
     3.5.4 DIET/LIFESTYLE
     3.5.5 OBESITY
     3.5.6 INFECTION OF THE PROSTATE GLAND
3.6 STAGES
     3.6.1 STAGE I
     3.6.2 STAGE II
     3.6.3 STAGE III
     3.6.4 STAGE IV
3.7 DIAGNOSIS
     3.7.1 DIGITAL RECTAL EXAM (DRE) 
     3.7.2 PROSTATE-SPECIFIC ANTIGEN (PSA) BLOOD TEST
     3.7.3 PROSTATE BIOPSY
     3.7.4 ULTRASOUND
     3.7.5 BONE SCAN
     3.7.6 CT SCAN AND MRI
     3.7.7 PET & SPECT SCANS
     3.7.8 LYMPH NODE BIOPSY
     3.7.9 PROSTASCINT MONOCLONAL ANTIBODY SCAN

CHAPTER 4 - MINIMALLY INVASIVE PROSTATE CANCER SURGICAL TECHNIQUES
4.1 INTRODUCTION
4.2 LAPAROSCOPIC SURGERY
4.3 BRACHYTHERAPY
4.4 CRYOSURGERY
4.5 ROBOTIC SURGERY

CHAPTER 5 - MARKET DYNAMICS
5.1 DRIVERS
     5.1.1 INCREASE IN ELDERLY MALE POPULATION
     5.1.2 INNOVATIVE TREATMENT OPTIONS
     5.1.3 SIGNIFICANT ADVANTAGE OVER TRADITIONAL METHOD
5.2 RESTRAINTS
     5.2.1 INEFFICIENCY OF SURGERY IN TREATING ADVANCED STAGE CANCER
     5.2.2 LACK OF TECHNOLOGICAL KNOWLEDGE
     5.2.3 HIGH ADVERSE SIDE EFFECTS

List Of Figure

FIG. 1 MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICE MARKET
(BY GEOGRAPHY) 
FIG. 2 PROSTATE CANCER MINIMALLY INVASIVE SURGICAL
FIG. 3 PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET 
(BY APPLICATION) 
FIG. 4 PROSTATE CANCER MINIMALLY INVASIVE LAPAROSCOPIC SURGERY DEVICE MARKET (BY TYPES) 
FIG. 5 PROSTATE CANCER MINIMALLY INVASIVE BRACHYTHERAPY DEVICE MARKET (BY TYPES) 
FIG. 6 PROSTATE CANCER MINIMALLY INVASIVE CRYOSURGERY DEVICE MARKET (BY TYPES) 
FIG. 7 PROSTATE CANCER MINIMALLY INVASIVE ROBOTIC SUSRGERY DEVICE MARKET (BY TYPES) 
FIG. 8 GROWING MALE POPULATION (2010 – 2050): AGED POPULATION
(>40 YEARS) IS SIGNIFICANTLY INCREASING
FIG. 9 MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICES MARKET SEGMENTATION
FIG. 10 PROSTATE CANCER MINIMALLY INVASIVE HAND DEVICE MARKET
FIG. 11 PROSTATE CANCER MINIMALLY INVASIVE POWERED SURGICAL DEVICE MARKET
FIG. 12 PROSTATE CANCER MINIMALLY INVASIVE MONIORING & VISUALIZATION DEVICE MARKET
FIG. 13 PROSTATE CANCER MINIMALLY INVASIVE ENDOOSURGICAL DEVICE MARKET
FIG. 14 MARKET SHARE OF MAJOR COMPETITORS IN MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICE MARKET (2011) 
Minimally Invasive Surgery Market And Prostate Cancer Marke

List Of Table 

TABLE 1 MINIMALLY INVASIVE PROSTATE CANCER SURGERY DEVICE MARKET (USD MILLION) 
TABLE 2 MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY TYPE (USD MILLION) 
TABLE 3 MINIMALLY INVASIVE PROSTATE CANCER LAPAROSCOPIC SURGERY MARKET (USD MILLION) 
TABLE 4 MINIMALLY INVASIVE PROSTATE CANCER BRACHYTHERAPY SURGERY MARKET (USD MILLION) 
TABLE 5 MINIMALLY INVASIVE PROSTATE CANCER CRYOSURGERY MARKET (USD MILLION) 
TABLE 6 MINIMALLY INVASIVE PROSTATE CANCER ROBOTIC SURGERY MARKET (USD MILLION) 
TABLE 7 MINIMALLY INVASIVE PROSTATE CANCER SURGERY HAND INSTRUMENTS MARKET (USD MILLION) 
TABLE 8 MINIMALLY INVASIVE PROSTATE CANCER SURGERY POWERED SURGICAL DEVICES MARKET (USD MILLION) 
TABLE 9 MINIMALLY INVASIVE PROSTATE CANCER SURGERY MONITORING & VISUALIZATION DEVICES MARKET (USD MILLION) 
TABLE 10 MINIMALLY INVASIVE PROSTATE CANCER SURGERY ENDOSURGICAL DEVICES MARKET (USD MILLION) 
TABLE 11 U.S. MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 12 U.S. MINIMALY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 13 CANADA MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 14 CANADA MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 15 U.K. MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 16 U.K. MINIMALY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 17 GERMANY MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 18 GERMANY MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 19 FRANCE MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 20 FRANCE MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 21 ITALY MINIMALLY INVASIVE PROSTATE CANCER SURGERY  (NUMBER OF PROCEDURES) 
TABLE 22 ITALY MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 23 SPAIN MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 
TABLE 24 SPAIN MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 
TABLE 25 ANGIODYNAMICS, INC. TOTAL REVENUES AND R&D EXPENSES (USD THOUSAND) 
TABLE 26 ANGIODYNAMICS, INC. BUSINESS SEGMENT REVENUE (USD THOUSAND) 
TABLE 27 BSD MEDICAL CORPORATION – TOTAL SALES & R&D EXPENDITURE (USD MILLION) 
TABLE 28 COVIDIEN AG  - TOTAL REVENUES & R&D EXPENDITURE (USD MILLION) 
TABLE 29 COVIDIEN AG - REVENUES BY SEGMENT (USD MILLION) 
TABLE 30 OLYMPUS CORPORATION - TOTAL REVENUES & R&D  EXPENDITURE (USD MILLION) 
TABLE 31 OLYMPUS CORPORATION - REVENUES BY SEGMENTS (USD MILLION) 
TABLE 32 SIEMENS HEALTHCARE – HEALTHCARE SEGMENT SALES & R&D EXPENSES (USD MILLION) 
TABLE 33 INTUITIVE SURGICAL, INC. – REVENUES & R&D EXPENSES (USD MILLION) 

Market Overview



Coming soon...

Enquiry Before Buying


Free Market Analysis


MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICE MARKET
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research